Tremendous progress has been made in the medical treatment of advanced colorectal cancer during the past 2 to 3 years, due to the availability of several new drugs. Of these new agents, irinotecan (CPT-11 [Camptosar]) seems
A. Benhammouda, MD
Advertisement
Articles by A. Benhammouda, MD
Advertisement
Latest Updated Articles
- European Experience With Irinotecan Plus Fluorouracil/Folinic Acid or Mitomycin
Published: August 1st 1998 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
How Supportive Care Methods Can Improve Oncology Outcomes
2
AQUILA Shows “Striking” Benefits With Daratumumab in Smoldering Myeloma
3
FDA Clears Phase 3 Lacutamab Protocol in Cutaneous T-Cell Lymphomas
4
Chlorotoxin-Based Therapy Shows Safety, Feasibility in Glioblastoma
5
